1. Home
  2. GILT vs WVE Comparison

GILT vs WVE Comparison

Compare GILT & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gilat Satellite Networks Ltd.

GILT

Gilat Satellite Networks Ltd.

HOLD

Current Price

$12.88

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$6.26

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GILT
WVE
Founded
1987
2012
Country
Israel
Singapore
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
GILT
WVE
Price
$12.88
$6.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
16
Target Price
$19.00
$29.81
AVG Volume (30 Days)
843.5K
3.4M
Earning Date
05-13-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$15.06
N/A
Revenue Next Year
$11.72
$85.67
P/E Ratio
$42.82
N/A
Revenue Growth
N/A
149.43
52 Week Low
$7.01
$5.02
52 Week High
$20.99
$21.73

Technical Indicators

Market Signals
Indicator
GILT
WVE
Relative Strength Index (RSI) 41.24 53.69
Support Level $11.28 $6.02
Resistance Level $13.43 $6.31
Average True Range (ATR) 0.82 0.29
MACD 0.10 0.07
Stochastic Oscillator 31.14 92.16

Price Performance

Historical Comparison
GILT
WVE

About GILT Gilat Satellite Networks Ltd.

Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company operates in three operating segments: Gilat Commercial Division, Gilat Defense Division, and Gilat Peru Division. The majority of its revenue is generated from the Gilat Commercial segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: